Therapeutic Efficacy Monotherapy Once-daily topical tazarotene 0.05% or 0.1% cream or gel effectively controlled signs and symptoms of plaque psoriasis in adult patients in randomized, single- or double-blind studies of 12 weeks duration. Clinical success (mild, minimal, or no psoriasis) rates were...
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect Background: Topical therapy providing initial improvement and maintenance of effect after treatment of the large majority of patients with limited, mild to...